LPL Financial
AMRX icon

LPL Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

LPL Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.35M Buy
116,467
+25,135
+28% +$453K ﹤0.01% 3623
2026
Q2 		$1.58M Buy
91,332
+19,643
+27% +$269K ﹤0.01% 4001
2026
Q1 		$891K Sell
71,689
-3,126
-4% -$42K ﹤0.01% 4279
2025
Q4 		$943K Sell
74,815
-10,576
-12% -$121K ﹤0.01% 4130
2025
Q3 		$855K Sell
85,391
-2,989
-3% -$26.8K ﹤0.01% 4146
2025
Q2 		$715K Buy
88,380
+1,748
+2% +$13.2K ﹤0.01% 4062
2025
Q1 		$726K Sell
86,632
-16,333
-16% -$136K ﹤0.01% 3815
2024
Q4 		$815K Buy
102,965
+10,093
+11% +$84.7K ﹤0.01% 3676
2024
Q3 		$773K Buy
92,872
+20,834
+29% +$163K ﹤0.01% 3631
2024
Q2 		$457K Sell
72,038
-3,853
-5% -$24.5K ﹤0.01% 3945
2024
Q1 		$460K Buy
75,891
+10,470
+16% +$59K ﹤0.01% 3858
2023
Q4 		$397K Buy
65,421
+1,201
+2% +$5.35K ﹤0.01% 3850
2023
Q3 		$271K Buy
64,220
+5,997
+10% +$22.4K ﹤0.01% 4006
2023
Q2 		$180K Sell
58,223
-159
-0.3% -$339 ﹤0.01% 4186
2023
Q1 		$81.2K Buy
58,382
+2,635
+5% +$5.25K ﹤0.01% 4244
2022
Q4 		$111K Buy
55,747
+9,629
+21% +$21.6K ﹤0.01% 4142
2022
Q3 		$93K Buy
46,118
+8,783
+24% +$24.6K ﹤0.01% 4124
2022
Q2 		$119K Buy
37,335
+1,358
+4% +$4.92K ﹤0.01% 4092
2022
Q1 		$150K Sell
35,977
-5,798
-14% -$25.7K ﹤0.01% 3899
2021
Q4 		$200K Buy
41,775
+3,147
+8% +$15.7K ﹤0.01% 3983
2021
Q3 		$206K Buy
38,628
+6,006
+18% +$30.2K ﹤0.01% 3961
2021
Q2 		$167K Buy
32,622
+2,383
+8% +$13.5K ﹤0.01% 3956
2021
Q1 		$204K Buy
30,239
+6,604
+28% +$36.6K ﹤0.01% 3754
2020
Q4 		$108K Buy
23,635
+6,775
+40% +$30K ﹤0.01% 3667
2020
Q3 		$65K Buy
+16,860
New +$72.1K ﹤0.01% 3413

Other funds holding AMRX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

LPL Financial's AMRX Position: Q3 2026 in Review

LPL Financial increased its Amneal Pharmaceuticals (AMRX) stake by 28% in Q3 2026, buying an estimated $453K and bringing the position to 116,467 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3623.

LPL Financial first reported a position in AMRX in Q3 2020 and has held it in 25 quarters since. 219 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • LPL Financial held 116,467 shares of Amneal Pharmaceuticals worth $2.35M as of Q3 2026.
  • LPL Financial bought 25,135 Amneal Pharmaceuticals shares in Q3 2026, an estimated $453K.
  • Amneal Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #3623 holding.
  • LPL Financial first reported a position in Amneal Pharmaceuticals in Q3 2020 and has held it in 25 quarters since.
  • 219 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.